牛牛AI助理已提取核心訊息
Panbela Therapeutics, Inc., represented by ROTH CAPITAL PARTNERS, LLC, has formally requested the U.S. Securities and Exchange Commission (SEC) to declare its Registration Statement on Form S-1 effective at 5:30 p.m. Eastern time on January 25, 2024. This request, made under Rule 461 of the Securities Act of 1933, aims for the Registration Statement to be effective as soon as possible after the specified time. Additionally, in compliance with Rule 460, ROTH CAPITAL PARTNERS has distributed the Preliminary Prospectus dated January 25, 2024, to ensure adequate distribution. The placement agent also confirms adherence to Rule 15c2-8 under the Securities Exchange Act of 1934.
Panbela Therapeutics, Inc., represented by ROTH CAPITAL PARTNERS, LLC, has formally requested the U.S. Securities and Exchange Commission (SEC) to declare its Registration Statement on Form S-1 effective at 5:30 p.m. Eastern time on January 25, 2024. This request, made under Rule 461 of the Securities Act of 1933, aims for the Registration Statement to be effective as soon as possible after the specified time. Additionally, in compliance with Rule 460, ROTH CAPITAL PARTNERS has distributed the Preliminary Prospectus dated January 25, 2024, to ensure adequate distribution. The placement agent also confirms adherence to Rule 15c2-8 under the Securities Exchange Act of 1934.
由ROTH CAPITAL PARTNERS, LLC代表的Panbela Therapeutics, Inc. 已正式要求美國證券交易委員會（SEC）宣佈其S-1表格的註冊聲明於美國東部時間2024年1月25日下午5點30分生效。該請求是根據1933年《證券法》第461條提出的，旨在使註冊聲明在規定時間後儘快生效。此外，根據第460條，ROTH CAPITAL PARTNERS已分發了2024年1月25日的初步招股說明書，以確保充分分配。配售機構還確認遵守1934年《證券交易法》第15c2-8條。
由ROTH CAPITAL PARTNERS, LLC代表的Panbela Therapeutics, Inc. 已正式要求美國證券交易委員會（SEC）宣佈其S-1表格的註冊聲明於美國東部時間2024年1月25日下午5點30分生效。該請求是根據1933年《證券法》第461條提出的，旨在使註冊聲明在規定時間後儘快生效。此外，根據第460條，ROTH CAPITAL PARTNERS已分發了2024年1月25日的初步招股說明書，以確保充分分配。配售機構還確認遵守1934年《證券交易法》第15c2-8條。
有用
沒用